SEI Investments’s Amicus Therapeutics FOLD Stock Holding History

SEI Investments’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Sell	87,585 -129,332	-60%	-$1.85M	﹤0.01%	2233
2025 Q4	$3.09M	Sell	216,917 -90,715	-29%	-$891K	﹤0.01%	1637
2025 Q3	$2.42M	Buy	307,632 +66,343	+27%	+$472K	﹤0.01%	1621
2025 Q2	$1.38M	Buy	241,289 +55,601	+30%	+$359K	﹤0.01%	1790
2025 Q1	$1.52M	Sell	185,688 -33,226	-15%	-$307K	﹤0.01%	1738
2024 Q4	$2.06M	Sell	218,914 -3,359	-2%	-$34.9K	﹤0.01%	1673
2024 Q3	$2.37M	Sell	222,273 -19,858	-8%	-$216K	﹤0.01%	1609
2024 Q2	$2.4M	Buy	242,131 +19,416	+9%	+$199K	﹤0.01%	1556
2024 Q1	$2.62M	Buy	222,715 +19,366	+10%	+$248K	﹤0.01%	1499
2023 Q4	$2.89M	Buy	203,349 +40,864	+25%	+$464K	﹤0.01%	1438
2023 Q3	$1.98M	Sell	162,485 -76,606	-32%	-$988K	﹤0.01%	1606
2023 Q2	$3M	Sell	239,091 -29,376	-11%	-$349K	0.01%	1452
2023 Q1	$2.98M	Sell	268,467 -45,614	-15%	-$562K	0.01%	1435
2022 Q4	$3.83M	Sell	314,081 -89,368	-22%	-$1.01M	0.01%	1169
2022 Q3	$4.21M	Sell	403,449 -59,682	-13%	-$665K	0.01%	1171
2022 Q2	$4.97M	Buy	463,131 +24,791	+6%	+$204K	0.01%	1096
2022 Q1	$4.15M	Sell	438,340 -7,342	-2%	-$68.8K	0.01%	1203
2021 Q4	$5.15M	Sell	445,682 -15,311	-3%	-$171K	0.01%	1123
2021 Q3	$4.4M	Sell	460,993 -10,092	-2%	-$103K	0.01%	1145
2021 Q2	$4.54M	Buy	471,085 +23,152	+5%	+$226K	0.01%	1130
2021 Q1	$5.2M	Sell	447,933 -182,668	-29%	-$2.83M	0.01%	998
2020 Q4	$14.6M	Buy	630,601 +504	+0.1%	+$10.3K	0.04%	476
2020 Q3	$8.9M	Buy	630,097 +40,617	+7%	+$592K	0.03%	595
2020 Q2	$8.89M	Sell	589,480 -11,834	-2%	-$144K	0.03%	593
2020 Q1	$5.56M	Buy	601,314 +7,702	+1%	+$73.2K	0.02%	701
2019 Q4	$5.78M	Buy	593,612 +256,890	+76%	+$2.35M	0.02%	843
2019 Q3	$2.7M	Sell	336,722 -14,940	-4%	-$162K	0.01%	1200
2019 Q2	$4.39M	Buy	351,662 +20,511	+6%	+$260K	0.01%	992
2019 Q1	$4.5M	Buy	331,151 +50,005	+18%	+$611K	0.02%	963
2018 Q4	$3.4M	Hold	281,146	–	–	0.01%	1084
2018 Q3	$3.4M	Buy	281,146 +247,004	+723%	+$3.45M	0.01%	1055
2018 Q2	$534K	Buy	34,142 +33,910	+14,616%	+$513K	﹤0.01%	1792
2018 Q1	$3K	Hold	232	–	–	﹤0.01%	3164
2017 Q4	$3K	Buy	232 +12	+5%	+$165	﹤0.01%	3037
2017 Q3	$3K	Hold	220	–	–	﹤0.01%	2921
2017 Q2	$2K	Buy	+220	New	+$1.77K	﹤0.01%	2862
2015 Q4	–	Sell	-47,832	Closed	-$669K	–	2573
2015 Q3	$669K	Buy	+47,832	New	+$750K	0.01%	1181

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

SEI Investments's FOLD Position: Q1 2026 in Review

SEI Investments reduced its Amicus Therapeutics (FOLD) stake by 60% in Q1 2026, selling an estimated $1.85M and leaving 87,585 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

SEI Investments first reported a position in FOLD in Q3 2015 and has held it in 37 quarters since. The position peaked at $14.6M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

SEI Investments held 87,585 shares of Amicus Therapeutics worth $1.27M as of Q1 2026.
SEI Investments sold 129,332 Amicus Therapeutics shares in Q1 2026, an estimated $1.85M.
Amicus Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2233 holding.
SEI Investments first reported a position in Amicus Therapeutics in Q3 2015 and has held it in 37 quarters since.
SEI Investments's Amicus Therapeutics position peaked at $14.6M in Q4 2020.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.